QWM
ARKG icon

Quadcap Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Quadcap Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+4,786
New +$152K 0.02% 407
2024
Q2 		– Sell
-7,197
Closed -$207K – 385
2024
Q1 		$207K Sell
7,197
-271
-4% -$8.15K 0.05% 310
2023
Q4 		$245K Buy
+7,468
New +$203K 0.06% 285

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Quadcap Wealth Management's ARKG Position: Q2 2026 in Review

Quadcap Wealth Management opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 4,786 shares worth $201K. The stake represents 0.02% of the portfolio and ranks #407 among its holdings. This is a return to the name: Quadcap Wealth Management previously reported a position in ARKG as recently as Q1 2024.

Quadcap Wealth Management first reported a position in ARKG in Q4 2023 and has held it in 3 quarters since. The position peaked at $245K in Q4 2023. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Quadcap Wealth Management held 4,786 shares of ARK Genomic Revolution ETF worth $201K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new Quadcap Wealth Management position in Q2 2026.
  • ARK Genomic Revolution ETF made up 0.02% of Quadcap Wealth Management's portfolio in Q2 2026, its #407 holding.
  • Quadcap Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2023 and has held it in 3 quarters since.
  • Quadcap Wealth Management's ARK Genomic Revolution ETF position peaked at $245K in Q4 2023.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Quadcap Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.